Page last updated: 2024-08-24

1,7-phenanthroline and Esophageal Squamous Cell Carcinoma

1,7-phenanthroline has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, J; Liu, C; Ma, J; Wang, L; Ye, J; Zhong, X	1

Other Studies

1 other study(ies) available for 1,7-phenanthroline and Esophageal Squamous Cell Carcinoma

Article	Year
A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage. Biochemical pharmacology, 2019, Volume: 166 Topics: Antigens, CD; Antineoplastic Agents; DNA Damage; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Iron Compounds; Phenanthrolines; Reactive Oxygen Species; Receptors, Transferrin	2019

Article

Year

A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.

Biochemical pharmacology, 2019, Volume: 166

Topics: Antigens, CD; Antineoplastic Agents; DNA Damage; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Iron Compounds; Phenanthrolines; Reactive Oxygen Species; Receptors, Transferrin

2019